Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | PKM | P14618 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | DPP4 | P27487 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14655321 | 0.98 | SMN1; SMN2 (0.47) | SMN1; SMN2PKMGAACYP3A4CYP2C19 | |
| SCHEMBL5966926 | 0.98 | SMN1; SMN2 (0.47) | SMN1; SMN2PKMGAACYP3A4CYP2C19 | |
| SCHEMBL24322495 | 0.84 | SMN1; SMN2 (0.54) | SMN1; SMN2PKMGAACYP3A4CYP2C19 | |
| Hydrochloric Acid SCHEMBL15941517 | 0.83 | SMN1; SMN2 (0.44) | SMN1; SMN2PKMGAACYP3A4CYP2C19 | |
| SCHEMBL14396537 | 0.82 | SMN1; SMN2 (0.50) | SMN1; SMN2PKMGAACYP3A4CYP2C19 | |
| SCHEMBL6165804 | 0.82 | SMN1; SMN2 (0.50) | SMN1; SMN2PKMGAACYP3A4CYP2C19 | |
| SCHEMBL5436113 | 0.82 | SMN1; SMN2 (0.50) | SMN1; SMN2PKMGAACYP3A4CYP2C19 | |
| SCHEMBL5966905 | 0.80 | DPP4 (0.60) | CYP3A4CYP2C19DPP4 | |
| SCHEMBL3628073 | 0.80 | DPP4 (0.60) | CYP3A4CYP2C19DPP4 | |
| SCHEMBL27507785 | 0.80 | DPP4 (0.60) | CYP3A4CYP2C19DPP4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220122691-A1 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | Psomagen Inc. (US) | 2022-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220122691-A1 | HtrA Inhibitors and CagA Inhibitors and Use Thereof | HTRA1, GIPR, HPN | SMN1; SMN2 4226/4885PKM 4535/4885GAA 1981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.